Home IPO-bound Aduro snags Big Pharma cancer immunotherapy deal
 

Keywords :   


IPO-bound Aduro snags Big Pharma cancer immunotherapy deal

2015-03-30 11:22:11| Biotech - Topix.net

Tiny Aduro Biotech Inc. hopes to put the STING on cancer with a potential $750 million deal between the Berkeley company and drug giant Novartis AG. The deal centers on experimental synthetic small molecules, developed by Aduro, that could be the latest weapon in the hot field of cancer immunotherapy.

Tags: big deal cancer pharma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.10Atlantic Tropical Weather Outlook
07.10Hurricane Milton Forecast Discussion Number 9
07.10Hurricane Milton Wind Speed Probabilities Number 9
07.10Hurricane Milton Public Advisory Number 9
07.10Hurricane Milton Forecast Advisory Number 9
07.10Eastern North Pacific Tropical Weather Outlook
07.10Hurricane Milton Update Statement
07.10Summary for Hurricane Milton (AT4/AL142024)
More »